Research programme: viral infection therapeutics - FUJIFILM Toyama Chemical
Alternative Names: T-1106Latest Information Update: 29 Oct 2018
Price :
$50 *
At a glance
- Originator Toyama Chemical
- Class
- Mechanism of Action DNA-directed RNA polymerase inhibitors; Hepatitis C virus NS 5 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Hepatitis C
- Discontinued HIV infections; Yellow fever
Most Recent Events
- 01 Dec 2012 No development reported - Preclinical for Hepatitis C in Japan (PO)
- 31 Jan 2010 T 1106 is still in preclinical trials for Hepatitis C in Japan
- 31 Jan 2010 Discontinued - Preclinical for HIV infections in Japan (unspecified route)